Company overview
Basic information
Company name
Dr Verslas, UAB
Company code
302417821
VAT code
LT100009572011
Registered address
Vilniaus r. sav., Nemėžio sen., Didžiasalio k., Šiaurės g. 28, LT-13264
Registration date
2009-07-13
Company age: 17 y. 3 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://drverslas.eu
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
New construction
Ownership form
Private without foreign capital
UAB "Dr Verslas"
Company code: 302417821
Address: Vilniaus r. sav., Nemėžio sen., Didžiasalio k., Šiaurės g. 28, LT-13264
VAT code: LT100009572011
Description
This description was generated by artificial intelligence.
Dr Verslas, UAB (company code 302417821) is an operational private limited liability company registered in 2009. It is classified as a private, nationally owned non-financial company with private property ownership, meaning Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. The company is governed by a CEO only and is assessed as medium-sized. Its activity is registered under EVRK code F.41.00.10, New construction. The company is based in Didžiasalio k., Nemežio sen., Vilnius District Municipality, Vilnius County.
In financial year 2025, revenue amounted to EUR 4.70 million, compared with EUR 5.19 million in 2024 and EUR 2.47 million in 2023. Net profit fell to EUR 8.6 thousand in 2025 from EUR 902.6 thousand a year earlier, bringing the profit margin down to 0.2%. Equity stood at EUR 1.36 million, total assets at EUR 2.16 million, and liabilities at EUR 810.6 thousand. The latest workforce figure is for so far in 2026, when the company averaged 76 employees, down from 88 in 2025, while the average monthly wage rose to EUR 1,627.15. The estimated annual payroll was EUR 1.48 million.
In financial year 2025, revenue amounted to EUR 4.70 million, compared with EUR 5.19 million in 2024 and EUR 2.47 million in 2023. Net profit fell to EUR 8.6 thousand in 2025 from EUR 902.6 thousand a year earlier, bringing the profit margin down to 0.2%. Equity stood at EUR 1.36 million, total assets at EUR 2.16 million, and liabilities at EUR 810.6 thousand. The latest workforce figure is for so far in 2026, when the company averaged 76 employees, down from 88 in 2025, while the average monthly wage rose to EUR 1,627.15. The estimated annual payroll was EUR 1.48 million.
Download a detailed company report
Make confident decisions with all the information about Dr Verslas, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.